Dexcom Rumored To Be In Talks To Acquire Insulet

Dexcom may be planning to purchase Insulet to enter the insulin pump market and transform itself into a diabetes tech giant.

Dexcom's HQ in San Diego, California • Source: Shutterstock

DexCom is reported to be in talks with Insulet to acquiring the insulin pump manufacturer, as reported by Bloomberg on 23 May.

The deal, which would combine Dexcom’s $31.8bn market cap with Insulet’s $14.1bn market cap, would form an indisputable giant in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business